BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,145,510 | -17.0% | 30,353 | +0.3% | 0.02% | -22.7% |
| Q2 2023 | $1,379,314 | +21.4% | 30,275 | +8.1% | 0.02% | +4.8% |
| Q1 2023 | $1,135,788 | -19.1% | 28,003 | +1.6% | 0.02% | -38.2% |
| Q4 2022 | $1,404,211 | -3.9% | 27,550 | +1.6% | 0.03% | -26.1% |
| Q3 2022 | $1,461,000 | -15.5% | 27,117 | +0.7% | 0.05% | -11.5% |
| Q2 2022 | $1,730,000 | -17.2% | 26,934 | -0.1% | 0.05% | -23.5% |
| Q1 2022 | $2,090,000 | -9.1% | 26,954 | +0.6% | 0.07% | -8.1% |
| Q4 2021 | $2,299,000 | +10.7% | 26,785 | +3.7% | 0.07% | -2.6% |
| Q3 2021 | $2,077,000 | -0.5% | 25,819 | -0.4% | 0.08% | -9.5% |
| Q2 2021 | $2,087,000 | -4.7% | 25,931 | -0.1% | 0.08% | -28.2% |
| Q1 2021 | $2,189,000 | +7.3% | 25,953 | +2.1% | 0.12% | -1.7% |
| Q4 2020 | $2,040,000 | -21.4% | 25,428 | -21.2% | 0.12% | -33.1% |
| Q3 2020 | $2,596,000 | -7.1% | 32,280 | -0.5% | 0.18% | -16.0% |
| Q2 2020 | $2,794,000 | +5.6% | 32,448 | -0.4% | 0.21% | -15.5% |
| Q1 2020 | $2,646,000 | +1216.4% | 32,588 | +1253.9% | 0.25% | +904.0% |
| Q4 2019 | $201,000 | -4.7% | 2,407 | -0.4% | 0.02% | -13.8% |
| Q3 2019 | $211,000 | -11.0% | 2,417 | -28.7% | 0.03% | -63.8% |
| Q2 2015 | $237,000 | +8.2% | 3,391 | +6.0% | 0.08% | +2.6% |
| Q1 2015 | $219,000 | -10.6% | 3,198 | -4.4% | 0.08% | -16.1% |
| Q4 2014 | $245,000 | – | 3,345 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |